Biotechnology, conceptual illustration

UVM Health Taps LunaPBC, Invitae on Genomic Testing Pilot Project

The pilot project will provide information for 147 genes that are well-established indicators of increased risk for certain diseases for which clinical treatment guidelines are established.
Source: Natali_Mis/Getty Images

RNA-Seq Research Expands Human Genome by Nearly 5K Genes

Johns Hopkins researchers assemble thousands of RNA-Seq experiments to create a new, comprehensive catalog of human genes and transcripts
EKF’s PointMan works by enriching the DNA sample for the point-mutated sequence

Case Study: Liquid Biopsy in Cancer Identification and Treatment

The initial diagnosis of cancer is usually based on taking a physical biopsy and then a skilled interpretation by a pathologist followed by tumor...
(L-R): Paul Saunders

WuXi NextCODE, New Subsidiary Join $400M Ireland Genomics R&D Hub

Genomics Medicine Ireland will become the Irish subsidiary of WuXi NextCODE, with plans to create up to 600 jobs over five years.

HTG, Illumina Expand IVD Test Collaboration to Autoimmune, CV, Fibrosis Disorders

HTG Molecular Diagnostics said today it has expanded a 4½-year-old agreement with Illumina allowing for development of in-vitro diagnostic (IVD) test kits for use...
Structure of an antibody

Mologic Readies Fast, Inexpensive COVID-19 Antibody Tests in the UK

Mologic is poised to start commercial-scale manufacture and rollout of both its laboratory ELISA, and low-cost—potentially £1 per test—lateral flow point-of-need coronavirus antibody tests, which could be available in the UK within weeks.
BioreclamationIVT said today it has acquired Asterand Bioscience™ for an undisclosed price

Expanding Offerings to Clinical Dx Developers, BioreclamationIVT Acquires Asterand Bioscience

Buyer aims to expand services for developers of diagnostics and drugs by supporting clinical diagnostic assay development and testing
Berg will partner with Massachusetts General Hospital and Brigham and Women's Hospital to study potential biomarkers for Alzheimer's and other neurodegenerative disorders from Harvard Biomarker Study biospecimens. [Source:]

DiamiR Nabs Grant to Develop Alzheimer’s Disease Diagnostic

The $492K award from the Alzheimer's Drug Discovery Foundation Diagnostics Accelerator will aid in the development of a blood-based test for circulating brain-enriched microRNAs as peripheral biomarkers of neurodegeneration.
Salim Essakali

Study Confirms Clinical Utility of Qiagen NGS Reader

Qiagen's GeneReader NGS system confirmed for detecting gene variants clinically relevant in detecting colorectal cancer.
[Source: Cancer Genetics]

Forging a New Course: Q&A with John Roberts, CEO of Cancer Genetics

New company CEO John Roberts details the company's new direction after the departure of long-time CEO Panna Sharma earlier this year
Scroll Up